3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
188
Leukemia, Lymphocytic, Chronic, B-Cell
69
Myelodysplastic Syndromes
47
Recurrence
30
Leukemia
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, Mantle-Cell
20
Leukemia, Myelomonocytic, Chronic
19
Hematologic Neoplasms
14
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Non-Hodgkin
13
Lymphoma
13
Leukemia, Biphenotypic, Acute
13
Burkitt Lymphoma
13
Lymphoma, B-Cell, Marginal Zone
12
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
11
Neoplasms
10
Waldenstrom Macroglobulinemia
8
Myeloproliferative Disorders
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
7
Neoplasm, Residual
6
Leukemia, Myeloid
5
Blastic Plasmacytoid Dendritic Cell Neoplasm
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
GATA2 Deficiency
4
Leukemia, Monocytic, Acute
3
Immunoglobulin Light-chain Amyloidosis
3
Interventions
fludarabine
4
Lenalidomide
4
Cyclophosphamide
4
fludarabine phosphate
3
Whole-Body Irradiation
3
Dexamethasone
3
Sirolimus
2
Mycophenolic Acid
2
venetoclax
1
sargramostim
1
plerixafor
1
pegylated granulocyte colony-stimulating factor
1
montanide ISA 51
1
itacitinib
1
isatuximab
1
incomplete Freund's adjuvant
1
ferric pyrophosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
carfilzomib
1
auricularum
1
Stem Cell Transplantation
1
Specimen Handling
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Hyaluronoglucosaminidase
1
High-Throughput Screening Assays
1
Hematopoietic Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Plasma Cell
×
venetoclax
×
1 year
×
Clear all
NCT03123029
2026-01-30
Expanded Access to Venetoclax
AbbVie
Available